BACE1 elevation is associated with aberrant limbic axonal sprouting in epileptic CD1 mice

Experimental Neurology

Volumn 235, Issue 1, 2012, Pages 228-237

  Yan, Xiao Xin ^a,c   Cai, Yan ^a,b   Zhang, Xue Mei ^b,d   Luo, Xue Gang ^a   Cai, Huaibin ^e   Rose, Gregory M ^b,c   Patrylo, Peter R ^b,c  

^a The First People s Hospital of Changde City)   (China)

^b SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SOUTHERN ILLINOIS UNIVERSITY   (United States)

^d HARBIN MEDICAL UNIVERSITY   (China)

^e NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Aberrant neuroplasticity; Alzheimer's disease; Beta secretase; Dystrophic neurites; Mossy fiber sprouting; Temporal lobe epilepsy

Indexed keywords

BETA SECRETASE 1; MICROTUBULE ASSOCIATED PROTEIN 2; NERVE CELL ADHESION MOLECULE; NEUROMODULIN; NEUROPEPTIDE Y; PILOCARPINE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENTATE GYRUS; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; EPILEPTOGENESIS; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; HIPPOCAMPAL MOSSY FIBER; IMMUNOREACTIVITY; LIMBIC SYSTEM; MALE; MOUSE; NERVE CELL PLASTICITY; NERVE ENDING; NERVE SPROUTING; NEUROPIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIALYLATION; SYNAPTIC TRANSMISSION; TEMPORAL CORTEX; TEMPORAL LOBE EPILEPSY;

AMYGDALA; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ASPARTIC ACID ENDOPEPTIDASES; AXONS; CA3 REGION, HIPPOCAMPAL; EPILEPSY, TEMPORAL LOBE; MICE; NEURONS; PILOCARPINE; TEMPORAL LOBE;

EID: 84862795529     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2012.01.003     Document Type: Article

References (96)

1. Akman C.I., Ichise M., Olsavsky A., Tikofsky R.S., Van Heertum R.L., Gilliam F. Epilepsy duration impacts on brain glucose metabolism in temporal lobe epilepsy: results of voxel-based mapping. Epilepsy Behav. 2010, 17:373-380.
2. Akram A., Christoffel D., Rocher A.B., Bouras C., Kovari E., Perl D.P., Morrison J.H., Herrmann F.R., Haroutunian V., Giannakopoulos P., Hof P.R. Stereologic estimates of total spinophilin-immunoreactive spine number in area 9 and the CA1 field: relationship with the progression of Alzheimer's disease. Neurobiol. Aging 2008, 29:1296-1307.
3. Amatniek J.C., Hauser W.A., DelCastillo-Castaneda C., Jacobs D.M., Marder K., Bell K., Albert M., Brandt J., Stern Y. Incidence and predictors of seizures in patients with Alzheimer's disease. Epilepsia 2006, 47:867-872.
4. Arendt T. Alzheimer's disease as a disorder of mechanisms underlying structural brain self-organization. Neuroscience 2001, 102:723-765.
5. Ben-Ari Y. Epilepsies and neuronal plasticity: for better or for worse?. Dialogues Clin. Neurosci. 2008, 10:17-27.
6. Blizzard C.A., Chuckowree J.A., King A.E., Hosie K.A., McCormack G.H., Chapman J.A., Vickers J.C., Dickson T.C. Focal damage to the adult rat neocortex induces wound healing accompanied by axonal sprouting and dendritic structural plasticity. Cereb. Cortex 2011, 21:281-291.
7. Bonfanti L. PSA-NCAM in mammalian structural plasticity and neurogenesis. Prog. Neurobiol. 2006, 80:129-164.
8. Borges K., Gearing M., McDermott D.L., Smith A.B., Almonte A.G., Wainer B.H., Dingledine R. Neuronal and glial pathological changes during epileptogenesis in the mouse pilocarpine model. Exp. Neurol. 2003, 182:21-34.
9. Buckmaster P.S., Dudek F.E. Neuron loss, granule cell axon reorganization, and functional changes in the dentate gyrus of epileptic kainate-treated rats. J. Comp. Neurol. 1997, 385:385-404.
10. Cai Y., Xiong K., Zhang X.M., Cai H., Luo X.G., Feng J.C., Clough R.W., Struble R.G., Patrylo P.R., Chu Y., Kordower J.H., Yan X.X. beta-Secretase-1 elevation in aged monkey and Alzheimer's disease human cerebral cortex occurs around the vasculature in partnership with multisystem axon terminal pathogenesis and beta-amyloid accumulation. Eur. J. Neurosci. 2010, 32:1223-1238.
11. Cai Y., Zhang X.M., Macklin L.N., Cai H., Luo X.G., Oddo S., Laferla F.M., Struble R.G., Rose G.M., Patrylo P.R., Yan X.X. BACE1 elevation is involved in amyloid plaque development in the triple transgenic model of Alzheimer's disease: differential Abeta antibody labeling of early-onset axon terminal pathology. Neurotox. Res. 2012, 21:160-174.
12. Catterall W.A. From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron 2000, 26:13-25.
13. Chi Z.H., Wang X., Cai J.Q., Stoltenberg M., Danscher G., Wang Z.Y. Zinc transporter 3 immunohistochemical tracing of sprouting mossy fibres. Neurochem. Int. 2008, 52:1305-1309.
14. Claes L., Del-Favero J., Ceulemans B., Lagae L., Van Broeckhoven C., De Jonghe P. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am. J. Hum. Genet. 2001, 68:1327-1332.
15. Curia G., Longo D., Biagini G., Jones R.S., Avoli M. The pilocarpine model of temporal lobe epilepsy. J. Neurosci. Methods 2008, 172:143-157.
16. Dancause N., Barbay S., Frost S.B., Plautz E.J., Chen D., Zoubina E.V., Stowe A.M., Nudo R.J. Extensive cortical rewiring after brain injury. J. Neurosci. 2005, 25:10167-10179.
17. Dube C., Boyet S., Marescaux C., Nehlig A. Relationship between neuronal loss and interictal glucose metabolism during the chronic phase of the lithium-pilocarpine model of epilepsy in the immature and adult rat. Exp. Neurol. 2001, 167:227-241.
18. Esclapez M., Hirsch J.C., Ben-Ari Y., Bernard C. Newly formed excitatory pathways provide a substrate for hyperexcitability in experimental temporal lobe epilepsy. J. Comp. Neurol. 1999, 408:449-460.
19. Fabene P.F., Merigo F., Galie M., Benati D., Bernardi P., Farace P., Nicolato E., Marzola P., Sbarbati A. Pilocarpine-induced status epilepticus in rats involves ischemic and excitotoxic mechanisms. PLoS One 2007, 2:e1105.
20. Farah M.H., Pan B.H., Hoffman P.N., Ferraris D., Tsukamoto T., Nguyen T., Wong P.C., Price D.L., Slusher B.S., Griffin J.W. Reduced BACE1 activity enhances clearance of myelin debris and regeneration of axons in the injured peripheral nervous system. J. Neurosci. 2011, 31:5744-5754.
21. Geddes J.W., Cotman C.W. Plasticity in Alzheimer's disease: too much or not enough?. Neurobiol. Aging 1991, 12:330-333. (discussion 352-335).
22. Gentleman S.M., Nash M.J., Sweeting C.J., Graham D.I., Roberts G.W. Beta-amyloid precursor protein (beta APP) as a marker for axonal injury after head injury. Neurosci. Lett. 1993, 160:139-144.
23. Gouras G.K., Relkin N.R., Sweeney D., Munoz D.G., Mackenzie I.R., Gandy S. Increased apolipoprotein E epsilon 4 in epilepsy with senile plaques. Ann. Neurol. 1997, 41:402-404.
24. Hardy J. The amyloid hypothesis for Alzheimer's disease: a critical reappraisal. J. Neurochem. 2009, 110:1129-1134.
25. Hashimoto M., Masliah E. Cycles of aberrant synaptic sprouting and neurodegeneration in Alzheimer's and dementia with Lewy bodies. Neurochem. Res. 2003, 28:1743-1756.
26. Henry T.R., Mazziotta J.C., Engel J. Interictal metabolic anatomy of mesial temporal lobe epilepsy. Arch. Neurol. 1993, 50:582-589.
27. Holtmaat A., Svoboda K. Experience-dependent structural synaptic plasticity in the mammalian brain. Nat. Rev. Neurosci. 2009, 10:647-658.
28. Howell O.W., Silva S., Scharfman H.E., Sosunov A.A., Zaben M., Shatya A., McKhann G., Herzog H., Laskowski A., Gray W.P. Neuropeptide Y is important for basal and seizure-induced precursor cell proliferation in the hippocampus. Neurobiol. Dis. 2007, 26:174-188.
29. Hu X., Zhou X., He W., Yang J., Xiong W., Wong P., Wilson C.G., Yan R. BACE1 deficiency causes altered neuronal activity and neurodegeneration. J. Neurosci. 2010, 30:8819-8829.
30. + current. Pflugers Arch. 2011, 461:355-371.
31. Iijima T., Shimase C., Sawa H., Sankawa H. Spreading depression induces depletion of MAP2 in area CA3 of the hippocampus in a rat unilateral carotid artery occlusion model. J. Neurotrauma 1998, 15:277-284.
32. Isokawa M. Remodeling dendritic spines of dentate granule cells in temporal lobe epilepsy patients and the rat pilocarpine model. Epilepsia 2000, 41(Suppl. 6):S14-S17.
33. Isom L.L. Sodium channel beta subunits: anything but auxiliary. Neuroscientist 2001, 7:42-54.
34. Jacobs K.M., Graber K.D., Kharazia V.N., Parada I., Prince D.A. Postlesional epilepsy: the ultimate brain plasticity. Epilepsia 2000, 41(Suppl. 6):S153-S161.
35. Kim D.Y., Carey B.W., Wang H., Ingano L.A., Binshtok A.M., Wertz M.H., Pettingell W.H., He P., Lee V.M., Woolf C.J., Kovacs D.M. BACE1 regulates voltagegated sodium channels and neuronal activity. Nat. Cell Biol. 2007, 9:755-764.
36. Kim D.Y., Gersbacher M.T., Inquimbert P., Kovacs D.M. Reduced sodium channel Na(v)1.1 levels in BACE1-null mice. J. Biol. Chem. 2011, 286:8106-8116.
37. Kitazume S., Tachida Y., Oka R., Shirotani K., Saido T.C., Hashimoto Y. Alzheimer's beta-secretase, beta-site amyloid precursor protein-cleaving enzyme, is responsible for cleavage secretion of a Golgi-resident sialyltransferase. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:13554-13559.
38. Kuhl D.E., Engel J., Phelps M.E., Selin C. Epileptic patterns of local cerebral metabolism and perfusion in humans determined by emission computed tomography of 18FDG and 13NH3. Ann. Neurol. 1980, 8:348-360.
39. Kurz J.E., Moore B.J., Henderson S.C., Campbell J.N., Churn S.B. A cellular mechanism for dendritic spine loss in the pilocarpine model of status epilepticus. Epilepsia 2008, 49:1696-1710.
40. Laird F.M., Cai H., Savonenko A.V., Farah M.H., He K., Melnikova T., Wen H., Chiang H.C., Xu G., Koliatsos V.E., Borchelt D.R., Price D.L., Lee H.K., Wong P.C. BACE1, a major determinant of selective vulnerability of the brain to amyloid-beta amyloidogenesis, is essential for cognitive, emotional, and synaptic functions. J. Neurosci. 2005, 25:11693-11709.
41. Li S., Carmichael S.T. Growth-associated gene and protein expression in the region of axonal sprouting in the aged brain after stroke. Neurobiol. Dis. 2006, 23:362-373.
42. Li G.L., Farooque M., Lewen A., Lennmyr F., Holtz A., Olsson Y. MAP2 and neurogranin as markers for dendritic lesions in CNS injury. An immunohistochemical study in the rat. APMIS 2000, 108:98-106.
43. Lichtenthaler S.F., Dominguez D.I., Westmeyer G.G., Reiss K., Haass C., Saftig P., De Strooper B., Seed B. The cell adhesion protein P-selectin glycoprotein ligand-1 is a substrate for the aspartyl protease BACE1. J. Biol. Chem. 2003, 278:48713-48719.
44. Loane D.J., Pocivavsek A., Moussa C.E., Thompson R., Matsuoka Y., Faden A.I., Rebeck G.W., Burns M.P. Amyloid precursor protein secretases as therapeutic targets for traumatic brain injury. Nat. Med. 2009, 15:377-379.
45. Longo B., Vezzani A., Mello L.E. Growth-associated protein 43 expression in hippocampal molecular layer of chronic epileptic rats treated with cycloheximide. Epilepsia 2005, 46(Suppl. 5):125-128.
46. Luan T.Z., Qi J.P., Wang D.S., Chen Y.X. Expression of amyloid beta protein and amyloid precursor protein after focal brain ischemia in human. Zhonghua Yi Xue Za Zhi 2005, 85:1770-1772.
47. Luo X., Yan R. Inhibition of BACE1 for therapeutic use in Alzheimer's disease. Int. J. Clin. Exp. Pathol. 2010, 3:618-628.
48. Luo X., Prior M., He W., Hu X., Tang X., Shen W., Yadav S., Kiryu-Seo S., Miller R., Trapp B.D., Yan R. Cleavage of neuregulin-1 by BACE1 or ADAM10 protein produces differential effects on myelination. J. Biol. Chem. 2011, 286:23967-23974.
49. Luscher C., Malenka R.C. Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling. Neuron 2011, 69:650-663.
50. Mackenzie I.R., Miller L.A. Senile plaques in temporal lobe epilepsy. Acta Neuropathol. 1994, 87:504-510.
51. Magloczky Z. Sprouting in human temporal lobe epilepsy: excitatory pathways and axons of interneurons. Epilepsy Res. 2010, 89:52-59.
52. Mannix R.C., Zhang J., Park J., Lee C., Whalen M.J. Detrimental effect of genetic inhibition of B-site app-cleaving enzyme 1 on functional outcome after controlled cortical impact in young adult mice. J. Neurotrauma 2011, 28:1855-1861.
53. Marik S.A., Yamahachi H., McManus J.N., Szabo G., Gilbert C.D. Axonal dynamics of excitatory and inhibitory neurons in somatosensory cortex. PLoS Biol. 2010, 8:e1000395.
54. Mikkonen M., Soininen H., Kalvianen R., Tapiola T., Ylinen A., Vapalahti M., Paljarvi L., Pitkanen A. Remodeling of neuronal circuitries in human temporal lobe epilepsy: increased expression of highly polysialylated neural cell adhesion molecule in the hippocampus and the entorhinal cortex. Ann. Neurol. 1998, 44:923-934.
55. Minkeviciene R., Rheims S., Dobszay M.B., Zilberter M., Hartikainen J., Fulop L., Penke B., Zilberter Y., Harkany T., Pitkanen A., Tanila H. Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy. J. Neurosci. 2009, 29:3453-3462.
56. Miyazaki H., Oyama F., Wong H.K., Kaneko K., Sakurai T., Tamaoka A., Nukina N. BACE1 modulates filopodia-like protrusions induced by sodium channel beta4 subunit. Biochem. Biophys. Res. Commun. 2007, 361:43-48.
57. Moolman D.L., Vitolo O.V., Vonsattel J.P., Shelanski M.L. Dendrite and dendritic spine alterations in Alzheimer models. J. Neurocytol. 2004, 33:377-387.
58. Nadler J.V., Tu B., Timofeeva O., Jiao Y., Herzog H. Neuropeptide Y in the recurrent mossy fiber pathway. Peptides 2007, 28:357-364.
59. Nukina N., Kanazawa I., Mannen T., Uchida Y. Accumulation of amyloid precursor protein and beta-protein immunoreactivities in axons injured by cerebral infarct. Gerontology 1992, 38(Suppl. 1):10-14.
60. Palop J.J., Chin J., Roberson E.D., Wang J., Thwin M.T., Bien-Ly N., Yoo J., Ho K.O., Yu G.Q., Kreitzer A., Finkbeiner S., Noebels J.L., Mucke L. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron 2007, 55:697-711.
61. Patino G.A., Claes L.R., Lopez-Santiago L.F., Slat E.A., Dondeti R.S., Chen C., O'Malley H.A., Gray C.B., Miyazaki H., Nukina N., Oyama F., De Jonghe P., Isom L.L. A functional null mutation of SCN1B in a patient with Dravet syndrome. J. Neurosci. 2009, 29:10764-10778.
62. Patrylo P.R., Dudek F.E. Physiological unmasking of new glutamatergic pathways in the dentate gyrus of hippocampal slices from kainate-induced epileptic rats. J. Neurophysiol. 1998, 79:418-429.
63. Paxinos G., Franklin K.B.J. The Mouse Brain in Stereotaxic Coordinates 2004, Elsevier Academic Press, Amsterdam; Boston.
64. Pereno G.L., Beltramino C.A. Timed changes of synaptic zinc, synaptophysin and MAP2 in medial extended amygdala of epileptic animals are suggestive of reactive neuroplasticity. Brain Res. 2010, 1328:130-138.
65. Pollard H., Khrestchatisky M., Moreau J., Ben-Ari Y., Represa A. Correlation between reactive sprouting and microtubule protein expression in epileptic hippocampus. Neuroscience 1994, 61:773-787.
66. Posmantur R.M., Kampfl A., Taft W.C., Bhattacharjee M., Dixon C.E., Bao J., Hayes R.L. Diminished microtubule-associated protein 2 (MAP2) immunoreactivity following cortical impact brain injury. J. Neurotrauma 1996, 13:125-137.
67. Rao S.C., Dove G., Cascino G.D., Petersen R.C. Recurrent seizures in patients with dementia: frequency, seizure types, and treatment outcome. Epilepsy Behav. 2009, 14:118-120.
68. Saura C.A., Choi S.Y., Beglopoulos V., Malkani S., Zhang D., Shankaranarayana Rao B.S., Chattarji S., Kelleher R.J., Kandel E.R., Duff K., Kirkwood A., Shen J. Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration. Neuron 2004, 42:23-36.
69. Schmidt J.W., Catterall W.A. Biosynthesis and processing of the alpha subunit of the voltage-sensitive sodium channel in rat brain neurons. Cell 1986, 46:437-444.
70. Seeger G., Gartner U., Ueberham U., Rohn S., Arendt T. FAD-mutation of APP is associated with a loss of its synaptotrophic activity. Neurobiol. Dis. 2009, 35:258-263.
71. Sheng J.G., Boop F.A., Mrak R.E., Griffin W.S. Increased neuronal beta-amyloid precursor protein expression in human temporal lobe epilepsy: association with interleukin-1 alpha immunoreactivity. J. Neurochem. 1994, 63:1872-1879.
72. Shibley H., Smith B.N. Pilocarpine-induced status epilepticus results in mossy fiber sprouting and spontaneous seizures in C57BL/6 and CD-1 mice. Epilepsy Res. 2002, 49:109-120.
73. Shim K.S., Lubec G. Drebrin, a dendritic spine protein, is manifold decreased in brains of patients with Alzheimer's disease and Down syndrome. Neurosci. Lett. 2002, 324:209-212.
74. Shrimpton A.E., Schelper R.L., Linke R.P., Hardy J., Crook R., Dickson D.W., Ishizawa T., Davis R.L. A presenilin 1 mutation (L420R) in a family with early onset Alzheimer disease, seizures and cotton wool plaques, but not spastic paraparesis. Neuropathology 2007, 27:228-232.
75. Smith B.N., Dudek F.E. Short- and long-term changes in CA1 network excitability after kainate treatment in rats. J. Neurophysiol. 2001, 85:1-9.
76. Spampanato J., Escayg A., Meisler M.H., Goldin A.L. Functional effects of two voltage-gated sodium channel mutations that cause generalized epilepsy with febrile seizures plus type 2. J. Neurosci. 2001, 21:7481-7490.
77. Stokin G.B., Lillo C., Falzone T.L., Brusch R.G., Rockenstein E., Mount S.L., Raman R., Davies P., Masliah E., Williams D.S., Goldstein L.S. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 2005, 307:1282-1288.
78. Sutula T., Cascino G., Cavazos J., Parada I., Ramirez L. Mossy fiber synaptic reorganization in the epileptic human temporal lobe. Ann. Neurol. 1989, 26:321-330.
79. Taft W.C., Yang K., Dixon C.E., Hayes R.L. Microtubule-associated protein 2 levels decrease in hippocampus following traumatic brain injury. J. Neurotrauma 1992, 9:281-290.
80. Tang F.R., Loke W.K. Cyto-, axo- and dendro-architectonic changes of neurons in the limbic system in the mouse pilocarpine model of temporal lobe epilepsy. Epilepsy Res. 2010, 89:43-51.
81. Tolner E.A., van Vliet E.A., Holtmaat A.J., Aronica E., Witter M.P., da Silva F.H., Gorter J.A. GAP-43 mRNA and protein expression in the hippocampal and parahippocampal region during the course of epileptogenesis in rats. Eur. J. Neurosci. 2003, 17:2369-2380.
82. Tong Y., Zhou W., Fung V., Christensen M.A., Qing H., Sun X., Song W. Oxidative stress potentiates BACE1 gene expression and Abeta generation. J. Neural Transm. 2005, 112:455-469.
83. Uebachs M., Opitz T., Royeck M., Dickhof G., Horstmann M.T., Isom L.L., Beck H. Efficacy loss of the anticonvulsant carbamazepine in mice lacking sodium channel beta subunits via paradoxical effects on persistent sodium currents. J. Neurosci. 2010, 30:8489-8501.
84. Velliquette R.A., O'Connor T., Vassar R. Energy inhibition elevates beta-secretase levels and activity and is potentially amyloidogenic in APP transgenic mice: possible early events in Alzheimer's disease pathogenesis. J. Neurosci. 2005, 25:10874-10883.
85. Wang H., Song L., Laird F., Wong P.C., Lee H.K. BACE1 knock-outs display deficits in activity-dependent potentiation of synaptic transmission at mossy fiber to CA3 synapses in the hippocampus. J. Neurosci. 2008, 28:8677-8681.
86. Wen Y., Onyewuchi O., Yang S., Liu R., Simpkins J.W. Increased beta-secretase activity and expression in rats following transient cerebral ischemia. Brain Res. 2004, 1009:1-8.
87. Weyer S.W., Klevanski M., Delekate A., Voikar V., Aydin D., Hick M., Filippov M., Drost N., Schaller K.L., Saar M., Vogt M.A., Gass P., Samanta A., Jaschke A., Korte M., Wolfer D.P., Caldwell J.H., Muller U.C. APP and APLP2 are essential at PNS and CNS synapses for transmission, spatial learning and LTP. EMBO J. 2011, 30:2266-2280.
88. Wong H.K., Sakurai T., Oyama F., Kaneko K., Wada K., Miyazaki H., Kurosawa M., De Strooper B., Saftig P., Nukina N. beta Subunits of voltage-gated sodium channels are novel substrates of beta-site amyloid precursor protein-cleaving enzyme (BACE1) and gamma-secretase. J. Biol. Chem. 2005, 280:23009-23017.
89. Xiong K., Cai H., Luo X.G., Struble R.G., Clough R.W., Yan X.X. Mitochondrial respiratory inhibition and oxidative stress elevate beta-secretase (BACE1) proteins and activity in vivo in the rat retina. Exp. Brain Res. 2007, 181:435-446.
90. Yan X.X., Li T., Rominger C.M., Prakash S.R., Wong P.C., Olson R.E., Zaczek R., Li Y.W. Binding sites of gamma-secretase inhibitors in rodent brain: distribution, postnatal development, and effect of deafferentation. J. Neurosci. 2004, 24:2942-2952.
91. Yan X.X., Xiong K., Luo X.G., Struble R.G., Clough R.W. beta-Secretase expression in normal and functionally deprived rat olfactory bulbs: inverse correlation with oxidative metabolic activity. J. Comp. Neurol. 2007, 501:52-69.
92. Yu H., Saura C.A., Choi S.Y., Sun L.D., Yang X., Handler M., Kawarabayashi T., Younkin L., Fedeles B., Wilson M.A., Younkin S., Kandel E.R., Kirkwood A., Shen J. APP processing and synaptic plasticity in presenilin-1 conditional knockout mice. Neuron 2001, 31:713-726.
93. Zhang X., Poo M.M. Progress in neural plasticity. Sci. China Life Sci. 2010, 53:322-329.
94. Zhang X.M., Cai Y., Xiong K., Cai H., Luo X.G., Feng J.C., Clough R.W., Struble R.G., Patrylo P.R., Yan X.X. Beta-secretase-1 elevation in transgenic mouse models of Alzheimer's disease is associated with synaptic/axonal pathology and amyloidogenesis: implications for neuritic plaque development. Eur. J. Neurosci. 2009, 30:2271-2283.
95. Zhang X.M., Xiong K., Cai Y., Cai H., Luo X.G., Feng J.C., Clough R.W., Patrylo P.R., Struble R.G., Yan X.X. Functional deprivation promotes amyloid plaque pathogenesis in Tg2576 mouse olfactory bulb and piriform cortex. Eur. J. Neurosci. 2010, 31:710-721.
96. Zhao J., Fu Y., Yasvoina M., Shao P., Hitt B., O'Connor T., Logan S., Maus E., Citron M., Berry R., Binder L., Vassar R. Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis. J. Neurosci. 2007, 27:3639-3649.